| Financial Year |
March 31 2023 |
| Monetary Funds |
76,121,171.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,479,876.40 |
| Accounts Receivable |
40,448,673.72 |
| Advances to Suppliers |
7,509,836.80 |
| Other Receivables |
17,283,205.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
190,551,137.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,754,556.50 |
| Total Current Assets |
350,148,457.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
59,917,415.62 |
| Investment Properties |
-- |
| Fixed Assetes |
48,451,230.19 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,794,944.33 |
| R&D expenses |
1,403,991.69 |
| Goodwill |
63,455,993.03 |
| Long-Term Deferred and Prepaid Expenses |
1,448,954.48 |
| Deferred Income Tax Assets |
714,940.58 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
201,522,969.51 |
| Total Assets |
551,671,427.00 |
| Short-Term Loans |
70,953,386.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
17,190,484.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,851,101.94 |
| Taxes Payable |
44,967,977.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
166,314,693.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,642,239.11 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
307,041,602.72 |
| Long-term Loans |
5,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
819,124.27 |
| Deferred Income Tax Liabilities |
31,427.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,173,009.43 |
| Total Liabilities |
327,214,612.15 |
| Paid-In Capital(Or Share Stock) |
309,916,551.00 |
| Capital Surplus |
156,959,052.06 |
| Surplus Reserve |
4,855,407.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-286,714,719.62 |
| Minority Stockholder's Interest |
46,580,523.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
177,876,290.89 |
| Owner's Equity（Stockholder's Equity） |
224,456,814.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
551,671,427.00 |
